Evidence map›Paper›PMID 40220935›Full record

ArticleJournal of the American Society of Echocardiography : official publication of the American Society of Echocardiography2025

Development and Validation of a Novel Deep Learning Model to Predict Pharmacologic Closure of Patent Ductus Arteriosus in Premature Infants.

Puneet Sharma, Addison Gearhart, Guangze Luo, Anil Palepu, Cindy Wang, Joshua Mayourian, Kristyn Beam, Fotios Spyropoulos, Andrew J Powell, Philip Levy and 1 more

Abstract readValidation Study
In one paragraph

Article in Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Puneet SharmaDivision of Neonatology, Emory University School of Medicine, Atlanta, Georgia. Electronic address: puneet.sharma2@emory.edu.
Addison GearhartDepartment of Cardiology, Boston Children's Hospital, Boston, Massachusetts.
Guangze LuoDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Anil PalepuDepartment of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts.
Cindy WangDepartment of Statistics, Harvard University, Cambridge, Massachusetts.
Joshua MayourianDepartment of Cardiology, Boston Children's Hospital, Boston, Massachusetts.
Kristyn BeamDepartment of Neonatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Fotios SpyropoulosDivision of Newborn Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Andrew J PowellDepartment of Cardiology, Boston Children's Hospital, Boston, Massachusetts.
Philip LevyDivision of Newborn Medicine, Boston Children's Hospital, Boston, Massachusetts.
Andrew BeamDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.

Funding

Neonatal Research Training ProgramT32HD098061 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI Stella Kourembanas, Martha C. Sola-Visner · 2019 to 2026
$4.0M
Oxidative Stress and Mitochondrial Dysfunction in Chemogenetic Heart FailureK08HL168240 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Fotios Spyropoulos · 2023 to 2026
$735k
NHLBI NIH HHS K08 HL168240NICHD NIH HHS T32 HD098061
6 · The paper itself

Abstract

backgroundPatent ductus arteriosus (PDA) is associated with significant morbidity and mortality in preterm infants. Although pharmacotherapy can be effective, it is difficult to predict whether a patient will respond, leading to delays in care. Machine learning has emerged as a powerful tool to interpret clinical data to predict clinical outcomes but has not yet been applied to this question. The aim of this study was to train and validate a novel deep learning model to predict the likelihood of PDA closure after an initial course of pharmacotherapy in preterm infants.

methodsA retrospective cohort of 174 preterm infants who received pharmacologic treatment for PDA was identified. After collecting relevant perinatal data and pretreatment echocardiograms, the subjects were randomized into training and validation sets in a 70:30 split. Two distinct convolutional neural networks (CNN) were trained, one based on echocardiograms alone and the other on both echocardiograms and perinatal data. The performance of the CNNs was compared against controls of random forest and logistic regression models trained on perinatal data alone.

resultsThe rate of PDA closure after an initial course of pharmacotherapy was 60% in this cohort. The 174 echocardiograms collected for all subjects included 1,926 clips. A total of 121 infants (1,387 clips) were successfully randomized into the training set and 53 (539 clips) into the validation set. The multimodal CNN had an area under the curve (AUC) of 0.82, outperforming the imaging-only model (AUC = 0.66). Additionally, the multimodal CNN outperformed logistic regression (AUC = 0.66) and random forest (AUC = 0.74) models.

conclusionsThis novel, multimodal CNN shows promise for clinicians, who do not currently have a reliable tool to predict the success of PDA closure after an initial course of pharmacotherapy. This investigation represents the first attempt to use deep learning methodology to predict this outcome.

Indexed as

Deep LearningDuctus Arteriosus, PatentEchocardiographyFemaleHumansInfant, NewbornInfant, PrematureMaleReproducibility of ResultsRetrospective StudiesConvolutional neural networkEchocardiogramMachine learningPatent ductus arteriosusPharmacotherapyPrematurity

Identifiers

PMID40220935
PMCPMC12229758

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.